MAPELLI, Vittorio. Costs and efficacy ofolanzapine and risperidone in schizophrenia. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 8, n. 2, p. 53–60, 2007. DOI: 10.7175/fe.v8i2.241. Disponível em: https://provafe.seedstm.com/index.php/FE/article/view/241. Acesso em: 23 jul. 2025.